Enabling Breakthroughs in Antimicrobials

2 TO 4 NOVEL ANTIBIOTICS BY 2030

agar plate

We Invest...

In biotechnology companies that are developing treatments for patients suffering from life-threatening antimicrobial-resistant infections.
Our investments

We Build...

Partnerships to create a sustainable innovation ecosystem so that new treatments continue evolving alongside the threat of AMR.
The Threat of AMR

We Advocate...

For market reforms and policy solutions that change how society values these lifesaving drugs.
Who we are

Connect With Us

Contact